#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Scedosporium infection Follicular lymphoma stage II Myasthenia gravis Cholestatic pruritus Choroid melanoma Malignant peritoneal neoplasm Raynaud's phenomenon Follicle centre lymphoma follicular grade I II – III refractory Tuberous sclerosis complex Monogenic diabetes Non-small cell lung cancer recurrent Breast cancer metastatic Penile squamous cell carcinoma Anal cancer recurrent Colitis ulcerative More trials…

    Learn about Rare Diseases

    Urea cycle disorder – Trials in Disease Marfan’s syndrome – Diagnostics Familial haemophagocytic lymphohistiocytosis – Trials in Disease Pleural mesothelioma malignant – Diagnostics Hereditary angioedema with C1 esterase inhibitor deficiency – Treatment Nodal marginal zone B-cell lymphoma Marginal zone lymphoma refractory – Life with Disease Vascular malformation – Treatment Glomerulonephritis membranous – Basic Information Waldenstrom’s macroglobulinaemia recurrent – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rbp030.2 Repotrectinib Ceftriaxone Sodium Ixazomib Glibenclamide Adapalene SEVABERTINIB TETRODOTOXIN Lisaftoclax Balstilimab INSULIN DETEMIR ALENDRONATE SODIUM TRIHYDRATE Allo-647 Cpk850 ALLERGEN EXTRACTS Lidocaine Hydrochloride Vitamin A Bp Sirexatamab Carboplatin Sodium Picosulfate More therapies…

    Learn about Your Condition

    Meningococcal infection Fabry's disease Primary biliary cholangitis Tubulointerstitial nephritis Essential thrombocythaemia Prostatitis Escherichia coli Rhabdomyosarcoma recurrent Dyslipidaemia Bacteraemia Friedreich's ataxia Arterial stiffness Bone hypertrophy Hip fracture Transplantation complication Acromegaly More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Use of PRGF and Hypromellose Eye Drops for Treating Dry Eye Disease in Patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Dry eye
    Investigated Drugs:
    • Platelet Concentrate
    • Hypromellose
    • Sodium Chloride
    Spain

  • Study on the Effect of Clozapine on Immune Response in Patients with Parkinson’s Disease

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Clozapine
    France

  • Study of Brentuximab Vedotin with Drug Combination for Untreated CD30-expressing Peripheral T-cell Lymphoma Patients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Brentuximab Vedotin
    • Cyclophosphamide
    • Etoposide
    Czechia

  • Monitoring the Effects of Epirubicin, Cyclophosphamide, and Docetaxel in Women with Breast Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer female
    Investigated Drugs:
    • Epirubicin Hydrochloride
    • Cyclophosphamide
    • Docetaxel
    Sweden

  • Study comparing MB04 (etanercept biosimilar) with Enbrel in patients with moderate to severe rheumatoid arthritis who are taking methotrexate

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Etanercept
    Bulgaria Hungary Poland Romania

  • Study on Vaginal Tamoxifen for Improving Sexual Function in Women with Breast Cancer Experiencing Vulvovaginal Atrophy Symptoms

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Atrophic vulvovaginitis
    Investigated Drugs:
    • Tamoxifen Citrate
    Sweden
Previous Page
1 … 836 837 838 839 840 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!